[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].
Lists
Only you see this
Abstract
Elderly AML patients should be treated individually. The intermediate-dose cytarabine consolidation might not improve survival of elderly AML patients.
BibTeX
@inproceedings{zhao2013prognostic,
author = {Bing-Bing Zhao and Zheng Zhu and Pengpeng Xu and Junmin Li and Zhixiang Shen and Weili Zhao and Li Wang},
title = {{[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].}},
booktitle = {PubMed},
year = {2013},
}Loading related content...